Overview

An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and tolerability of topiramate compared to placebo in patients with binge eating disorder receiving Cognitive Behavior Therapy (CBT)
Phase:
Phase 3
Details
Lead Sponsor:
Janssen-Cilag Farmaceutica Ltda.
Treatments:
Topiramate